欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0702/001
药品名称Ondansetron 2mg/ml Solution for Injection
活性成分
    • Ondansetron dihydrate 2.0 mg/ml
剂型Solution for injection
上市许可持有人Noridem Enterprises Ltd, Evagorou & Makariou, Mitsi Building 3, Office 115, 1065 Nicosia, Cyprus
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Sweden (SE)
    • Greece (GR)
    • Austria (AT)
      Ondansetron Noridem 2 mg/ml Injektions- und Infusionslösung
    • Germany (DE)
    • Italy (IT)
    • Portugal (PT)
    • Slovakia (SK)
    • Spain (ES)
    • Romania (RO)
    • Netherlands (NL)
    • Czechia (CZ)
      Ondansetron Noridem
    • Belgium (BE)
    • Cyprus (CY)
      Ondansetron Noridem 2 mg/mL, Solution for injection
    • Denmark (DK)
      Ondansetron Noridem
    • Hungary (HU)
      Ondansetron Noridem 2mg/ml oldatos injekció
    • Norway (NO)
    • Poland (PL)
      Ondansetronum Noridem
    • Finland (FI)
许可日期2008/05/07
最近更新日期2025/04/22
药物ATC编码
    • A04AA01 ondansetron
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase